Comparative Pharmacology
Head-to-head clinical analysis: GO EVAC versus PEG LYTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GO EVAC versus PEG LYTE.
GO-EVAC vs PEG-LYTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Promotes gastrointestinal motility by acting as a stimulant laxative, likely through direct irritation of the colonic mucosa and possibly via local effects on enteric neurons.
PEG-LYTE is an osmotic laxative that induces diarrhea by retaining water in the colon through the non-absorbable polyethylene glycol (PEG) and electrolytes, which prevent dehydration and electrolyte imbalance during bowel cleansing.
10 mg orally once daily, with or without food.
4 liters orally as a single dose or in divided doses for colonoscopy preparation.
None Documented
None Documented
4.5-6 hours in healthy volunteers; prolonged to 10-14 hours in elderly patients and those with moderate renal impairment (CrCl 30-50 mL/min).
Not applicable; PEG-3350 is minimally absorbed (<0.06%), thus systemic half-life is not clinically relevant. Local gut transit time ~1-2 hours.
Primarily renal; approximately 60% eliminated unchanged in urine within 24 hours, with 20% as metabolites. Biliary/fecal excretion accounts for 15-20%, and the remainder is metabolized via glucuronidation.
Primarily fecal (98-99%) as unchanged polyethylene glycol (PEG) 3350; negligible renal excretion (<0.2%). Electrolytes (sodium, potassium, bicarbonate) are partially absorbed and excreted renally.
Category C
Category C
Osmotic Laxative
Osmotic Laxative